Literature DB >> 11051281

Preservation of sight in diabetes: developing a national risk reduction programme.

L Garvican1, J Clowes, T Gillow.   

Abstract

BACKGROUND: Early treatment for diabetic retinopathy is effective at saving sight, but dependent on pre-symptomatic detection. Although 60% of people with diabetes have their eyes examined annually, few UK health authorities have systematic programmes that meet the British Diabetic Association's standards for sensitivity (> 80%) and specificity (> 95%). Screening is generally performed by general practitioners and optometrists, with some camera-based schemes, operated by dedicated staff. The National Screening Committee commissioned a group to develop a model and cost estimates for a comprehensive national risk-reduction programme. OPHTHALMOSCOPY: Evidence indicates that direct ophthalmoscopy using a hand-held ophthalmoscope does not give adequate specificity and sensitivity, and should be abandoned as a systematic screening technique. Indirect ophthalmoscopy using a slit lamp is sensitive and specific enough to be viable, and widespread availability in high street optometrists is an advantage, but the method requires considerable skill. PHOTOGRAPHIC SCHEMES: The principal advantage of camera-based screening is the capturing of an image, for patient education, review of disease progression, and quality assurance. Digital cameras are becoming cheaper, and are now the preferred option. The image is satisfactory for screening and may be transmitted electronically. With appropriate training and equipment, different professional groups might participate in programme delivery, based on local decisions. COST ISSUES: Considerable resources are already invested in ad hoc screening, with inevitable high referral rates incurring heavy outpatient costs. Treatment for advanced disease is expensive, but less likely to be effective. The costs of a new systematic screening and treatment programme appear similar to current expenditure, as a result of savings in treatment of late-presenting advanced retinopathy.
CONCLUSION: A systematic national programme based on digital photography is proposed.

Entities:  

Mesh:

Year:  2000        PMID: 11051281     DOI: 10.1046/j.1464-5491.2000.00353.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Spectral domain ocular coherence tomography findings pre- and post vitrectomy with fibrovascular membrane delamination for proliferative diabetic retinopathy.

Authors:  I Dooley; H Laviers; E Papavasileiou; C Mckechnie; H Zambarakji
Journal:  Eye (Lond)       Date:  2015-09-25       Impact factor: 3.775

Review 2.  Update on Screening for Sight-Threatening Diabetic Retinopathy.

Authors:  Peter H Scanlon
Journal:  Ophthalmic Res       Date:  2019-05-27       Impact factor: 2.892

3.  Is it safe to discharge treated proliferative diabetic retinopathy patients from the hospital eye service to a community screening programme?

Authors:  G S Negretti; G C Vafidis
Journal:  Eye (Lond)       Date:  2014-03-14       Impact factor: 3.775

4.  An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme.

Authors:  P H Scanlon; S Carter; C Foy; D Ratiram; B Harney
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

5.  Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease.

Authors:  H Murgatroyd; A Ellingford; A Cox; M Binnie; J D Ellis; C J MacEwen; G P Leese
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

Review 6.  The English national risk-reduction programme for preservation of sight in diabetes.

Authors:  Warren Gillibrand; Deborah Broadbent; Simon Harding; Jiten Vora
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

7.  Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition.

Authors:  Mark B Horton; Christopher J Brady; Jerry Cavallerano; Michael Abramoff; Gail Barker; Michael F Chiang; Charlene H Crockett; Seema Garg; Peter Karth; Yao Liu; Clark D Newman; Siddarth Rathi; Veeral Sheth; Paolo Silva; Kristen Stebbins; Ingrid Zimmer-Galler
Journal:  Telemed J E Health       Date:  2020-03-25       Impact factor: 3.536

8.  Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.

Authors:  R L Thomas; F Dunstan; S D Luzio; S Roy Chowdury; S L Hale; R V North; R L Gibbins; D R Owens
Journal:  BMJ       Date:  2012-02-22

9.  Grader agreement, and sensitivity and specificity of digital photography in a community optometry-based diabetic eye screening program.

Authors:  Luckni Sellahewa; Craig Simpson; Prema Maharajan; John Duffy; Iskandar Idris
Journal:  Clin Ophthalmol       Date:  2014-07-17

10.  A Multitask Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multicenter Analysis.

Authors:  Fangyao Tang; Xi Wang; An-Ran Ran; Carmen K M Chan; Mary Ho; Wilson Yip; Alvin L Young; Jerry Lok; Simon Szeto; Jason Chan; Fanny Yip; Raymond Wong; Ziqi Tang; Dawei Yang; Danny S Ng; Li Jia Chen; Marten Brelén; Victor Chu; Kenneth Li; Tracy H T Lai; Gavin S Tan; Daniel S W Ting; Haifan Huang; Haoyu Chen; Jacey Hongjie Ma; Shibo Tang; Theodore Leng; Schahrouz Kakavand; Suria S Mannil; Robert T Chang; Gerald Liew; Bamini Gopinath; Timothy Y Y Lai; Chi Pui Pang; Peter H Scanlon; Tien Yin Wong; Clement C Tham; Hao Chen; Pheng-Ann Heng; Carol Y Cheung
Journal:  Diabetes Care       Date:  2021-07-27       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.